Medigene AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1994-01-01
- Employees
- 86
- Market Cap
- $33.8M
- Website
- http://www.medigene.de
Medigene and EpimAb Partner to Develop Novel TCR-Guided T Cell Engagers for Solid Tumors
Medigene AG and EpimAb Biotherapeutics have formed a strategic co-development partnership to create off-the-shelf T cell receptor-guided T Cell Engagers (TCR-TCEs) for treating solid tumors and immune-related disorders.
Medigene AG Refocuses Strategy on TCR-Guided Therapies, Pauses MDG1015 Trial
Medigene AG is prioritizing R&D efforts towards generating 3S TCRs for off-the-shelf TCR-guided therapies, aiming for sensitive, specific, and safe cancer treatments.